Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer
Clinical trial NCT04224922 · COMPLETED
Trial details
- NCT number
- NCT04224922
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-07-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.